By www.marketscagr.com
Global Tumour-Induced Osteomalacia Market Size, Status And Forecast 2024-2031 Story
109
$ 3900
Tumour-Induced Osteomalacia Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Kyowa Kirin
Taizhou Hisound Pharmaceutical
Zhejiang Garden Biochemical High-tech
Kingdomway Nutrition
Amgen
Forgo Pharmaceuticals
Abbott
Solvay
GE Healthcare
Siemens